CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 GlobeNewswire July 31, 2025 Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results SOUTH SAN FRANSCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the […]

Freddie Mac Announces Second Quarter 2025 Financial Results

(Other OTC:FMCC),(OTC US:FMCC), MCLEAN, Va., July 31, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its Second Quarter 2025 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company's Form 10-Q and earnings press release, along with the Second Quarter 2025 financial results supplement

AestheticMatch Expands Luxury Concierge Platform, Connecting Patients to Screened Plastic Surgeons Nationwide

AestheticMatch, the Tribeca‑based digital concierge for cosmetic procedures, today announced the full national roll‑out of its free matching service that personally guides clients to qualified plastic surgeons who pass the company's rigorous screening process. Designed to cut through confusing online marketing and pay‑to‑play doctor listings, AestheticMatch delivers a white‑glove experience-from the first inquiry to post‑operative

Freddie Mac Announces Second Quarter 2025 Financial Results

Freddie Mac Announces Second Quarter 2025 Financial Results GlobeNewswire July 31, 2025 MCLEAN, Va., July 31, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its Second Quarter 2025 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company's Form 10-Q and earnings press release,

Vericel Reports Second Quarter 2025 Financial Results

(NasdaqGM:VCEL), Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million, with Adjusted EBITDA Margin Increase of More than 900 Basis Points to 21% Approximately 600 MACI Arthro Surgeons Trained

Vericel Reports Second Quarter 2025 Financial Results

Vericel Reports Second Quarter 2025 Financial Results GlobeNewswire July 31, 2025 Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million, with Adjusted EBITDA Margin Increase of More than 900

License Global Unveils Top Global Licensors 2025 Whitepaper

More than $307 billion reported in retail sales of licensed consumer products from the world’s biggest brand owners. NEW YORK, NY / ACCESS Newswire / July 31, 2025 / License Global, the licensing industry’s thought leader, today unveils its highly anticipated Top Global Licensors 2025 whitepaper, powered by SEGA, revealing how brand licensing demonstrates remarkable

Career Considerations: New research shows 26 per cent of professionals plan to change jobs, driven by desire for better benefits and perks

— Flexibility is the main reason workers want to stay put, while better perks and benefits tops the list of motivations for those who want to move — Workers are interested in pursuing new industries and contract work New research from talent solutions and business consulting firm Robert Half indicates most workers plan to stay

Career Considerations: Robert Half Research Finds 73% of Workers Plan to Stay in Their Current Roles Through 2025

— Flexibility, professional fulfillment and a positive workplace culture are contributing to job satisfaction — Some job seekers express interest in pursuing a career in contracting New research from talent solutions and business consulting firm Robert Half indicates most workers plan to stay put in their current roles – at least for now. The survey

Dun & Bradstreet Unveils D&B Healthcare Insights to Help Sales and Marketing Teams Across Industries Unlock Opportunities in the Healthcare Ecosystem

D&B Healthcare Insights, Available as an Add-On to D&B Hoovers, Elevates Sales & Marketing Strategies to Drive Commercial Success Dun & Bradstreet (NYSE:DNB), a leading global provider of business data and analytics, today announced the launch of D&B Healthcare Insights, a powerful new dataset designed to help sales and marketing teams uncover growth opportunities and

Scroll to Top